Predicting the risk of neurodegenerative diseases based on clinical microsignals
Ukrainian Neurosurgical Journal · 30.06.2026 · 32 (2) · 32-50
DOI: 10.25305/unj.341180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ukrainian Neurosurgical Journal, online erschienen am 30.06.2026. Verfasst von Yaroslav D. Bondarenko und 1 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Neurodegenerative diseases, in particular Parkinson’s disease, remain difficult to diagnose due to the late manifestation of classical motor symptoms, when significant neuronal degeneration has already occurred. A growing body of evidence suggests that subtle non-motor prodromal symptoms — so-called phenotypic microsignals (PMS) may precede the clinical manifestation of neurodegenerative diseases by several years. These symptoms reflect early neurochemical disturbances and disruptions of neural networks, especially in evolutionarily ancient brain structures vulnerable to α-synuclein pathology.
Objective
To identify and systematize early clinical phenotypic microsignals observed during initial outpatient visits and potentially associated with neurodegenerative processes, as well as to develop a clinical risk stratification tool for the prodromal stage based on retrospective analysis and prospective observation. Materials and methods: A combined retrospective-prospective observational study conducted at Kharkiv National Medical University during the period from January 2020 to August 2025. The study involved 112 patients aged 48 to 76 years, who were divided into three groups: group 1 (n=28, prodromal/non-manifest pathology), group 2 (n=56, manifest pathology (Alzheimer’s disease (n=16), Parkinson’s disease (n=28), dementia with Lewy bodies (n=9), progressive supranuclear palsy (n=3)), group 3 (control, n=28, individuals without clinical signs of neurodegenerative pathology, matched by age and sex). A 48-point PMS scale was developed and validated, assessing 30 clinical markers across cognitive, motor, autonomic, sensory and affective domains. Patients underwent comprehensive neurological examination, cognitive testing (MMSE — Mini-Mental State Examination, MoCA — Montreal Cognitive Assessment, FAB — Frontal Assessment Battery), magnetic resonance imaging and standardized assessment of non-motor symptoms. ROC analysis was used to evaluate the predictive accuracy of the scale.
Results
Patients with manifest neurodegenerative diseases had significantly higher PMS scale scores (mean value ‒ 27.8±6.3 points) compared with the prodromal group (11.4±3.8, p
Zitieren
APA
Bondarenko, Y. D., & Kauk, O. I. (2026). Predicting the risk of neurodegenerative diseases based on clinical microsignals. Ukrainian Neurosurgical Journal, 32(2), 32-50. https://doi.org/10.25305/unj.341180
Vancouver
Bondarenko YD, Kauk OI. Predicting the risk of neurodegenerative diseases based on clinical microsignals. Ukrainian Neurosurgical Journal. 2026;32(2):32-50. doi:10.25305/unj.341180
BibTeX
@article{Bondarenko2026,
author = {Bondarenko, Yaroslav D. and Kauk, Oksana I.},
title = {Predicting the risk of neurodegenerative diseases based on clinical microsignals},
journal = {Ukrainian Neurosurgical Journal},
year = {2026},
volume = {32},
number = {2},
pages = {32--50},
doi = {10.25305/unj.341180}
}
EUVIMED